Nineteen Companies. Twenty-One Investigations. Zero Admissions of Wrongdoing.

Updated

For those who still need proof that the pharmaceutical industry views human health as a commodity and patients as revenue streams, a new review published in the Journal of Law, Medicine & Ethics just handed it to you—documented, sourced, and damning. The study abstract declared: “Reported bribes amounted to about US $12.6 million, with sanctions exceeding…Continue reading Nineteen Companies. Twenty-One Investigations. Zero Admissions of Wrongdoing.

Crossing the Blood-Brain Barrier: The Erythritol Problem

Updated

That “sugar-free” label center stage on the protein bar wrapper? Or the one promising guilt-free bit of sweetness in our morning cup of coffee? Well, it turns out that hailed sugar-free sweetener might be doing something our bodies—and our brains—were not designed to handle. Yes, we’re talking about erythritol, the innocent sweetener that sits in…Continue reading Crossing the Blood-Brain Barrier: The Erythritol Problem

Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme

Updated

Pfizer is adding a new vaccine to its repertoire. The Big Pharma behemoth is preparing to bring a Lyme disease vaccine to market with its French partner, Valneva. The company recently announced the news, which comes at a time when public trust in pharmaceutical giants remains shaky, particularly following the contentious rollout of mRNA COVID…Continue reading Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme